Elevatus Welath Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $538K | Buy |
2,900
+790
| +37% | +$147K | 0.18% | 62 |
|
|
2025
Q1 | $442K | Sell |
2,110
-450
| -18% | -$94.3K | 0.25% | 57 |
|
|
2024
Q4 | $455K | Buy |
2,560
+1,175
| +85% | +$209K | 0.16% | 62 |
|
|
2024
Q3 | $274K | Sell |
1,385
-9,391
| -87% | -$1.85M | 0.09% | 73 |
|
|
2024
Q2 | $1.85M | Buy |
10,776
+9,087
| +538% | +$1.56M | 0.69% | 42 |
|
|
2024
Q1 | $307K | Sell |
1,689
-666
| -28% | -$121K | 0.12% | 70 |
|
|
2023
Q4 | $365K | Buy |
2,355
+918
| +64% | +$142K | 0.17% | 62 |
|
|
2023
Q3 | $214K | Buy |
+1,437
| New | +$214K | 0.19% | 63 |
|